CHMP recommends Santen's Verkazia for keratoconjunctivitis

EMA's CHMP recommended approval of Verkazia ciclosporin (Ikervis, Cyclokat) from Santen Pharmaceutical Co. Ltd. (Tokyo: 4536) to treat severe vernal keratoconjunctivitis, a rare eye allergy. The opht...